Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | ACHE | P22303 | 1/20 | 0.58 |
| ▸ | TYR | P14679 | 2/20 | 0.56 |
| ▸ | SLC28A3 | Q9HAS3 | 3/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 4/20 | 0.54 |
| ▸ | CA9 | Q16790 | 4/20 | 0.54 |
| ▸ | CA1 | P00915 | 3/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14773326 | 0.84 | EPHX2 (0.64) | POLBACHETYRSLC28A3EPHX2 | |
| SCHEMBL19861398 | 0.83 | ACHE (0.59) | POLBACHETYREPHX2PTGS1 | |
| SCHEMBL16942517 | 0.83 | EPHX2 (0.63) | POLBACHETYRSLC28A3EPHX2 | |
| SCHEMBL13348609 | 0.83 | EPHX2 (0.63) | POLBACHETYRSLC28A3EPHX2 | |
| SCHEMBL23479692 | 0.83 | SLC5A2 (0.68) | POLBACHETYRSLC28A3EPHX2 | |
| SCHEMBL23479740 | 0.83 | SLC5A2 (0.68) | POLBACHETYRSLC28A3EPHX2 | |
| SCHEMBL28789347 | 0.83 | SLC5A2 (0.68) | POLBACHETYRSLC28A3EPHX2 | |
| SCHEMBL23480032 | 0.83 | SLC5A2 (0.68) | POLBACHETYRSLC28A3EPHX2 | |
| SCHEMBL23031046 | 0.82 | TYR (0.63) | POLBACHETYREPHX2CA12 | |
| SCHEMBL4367625 | 0.82 | TYR (0.63) | POLBACHETYRSLC28A3SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190085007-A1 | 4-methylcatechol Derivatives and Uses Thereof | Thanares GmbH (DE) | 2019-03-21 | — | — | US | disclosed |
| US-20160347782-A1 | 4-methylcatechol Derivatives and Uses Thereof | Thanares GmbH (DE) | 2016-12-01 | — | — | US | disclosed |
| US-20160347782-A1 | 4-methylcatechol Derivatives and Uses Thereof | Thanares GmbH (DE) | 2016-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190085007-A1 | 4-methylcatechol Derivatives and Uses Thereof | ST3GAL3, GALE, DPP4 | POLB 4824/4885ACHE 1080/4885TYR 219/4885 |
| US-20160347782-A1 | 4-methylcatechol Derivatives and Uses Thereof | ST3GAL3, GALE, DPP4 | POLB 4824/4885ACHE 1080/4885TYR 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.